AAAAAA

   
Results: 1-3 |
Results: 3
Studies leading to the identification of ZD1839 (Iressa (TM)): An orally active, selective epidermal growth factor receptor tyrosine kinase inhibitortargeted to the treatment of cancer
Authors: Barker, AJ Gibson, KH Grundy, W Godfrey, AA Barlow, JJ Healy, MP Woodburn, JR Ashton, SE Curry, BJ Scarlett, L Henthorn, L Richards, L
Citation: Aj. Barker et al., Studies leading to the identification of ZD1839 (Iressa (TM)): An orally active, selective epidermal growth factor receptor tyrosine kinase inhibitortargeted to the treatment of cancer, BIOORG MED, 11(14), 2001, pp. 1911-1914
Evaluation of S-100 beta assays for the prediction of recurrence and prognosis in patients with AJCC stage I-III melanoma
Authors: Curry, BJ Farrelly, M Hersey, P
Citation: Bj. Curry et al., Evaluation of S-100 beta assays for the prediction of recurrence and prognosis in patients with AJCC stage I-III melanoma, MELANOMA RE, 9(6), 1999, pp. 557-567
MART-1 is expressed less frequently on circulating melanoma cells in patients who develop distant compared with locoregional metastases
Authors: Curry, BJ Myers, K Hersey, P
Citation: Bj. Curry et al., MART-1 is expressed less frequently on circulating melanoma cells in patients who develop distant compared with locoregional metastases, J CL ONCOL, 17(8), 1999, pp. 2562-2571
Risultati: 1-3 |